GB201311951D0 - Compounds - Google Patents
CompoundsInfo
- Publication number
- GB201311951D0 GB201311951D0 GBGB1311951.6A GB201311951A GB201311951D0 GB 201311951 D0 GB201311951 D0 GB 201311951D0 GB 201311951 A GB201311951 A GB 201311951A GB 201311951 D0 GB201311951 D0 GB 201311951D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB1311951.6A GB2515785A (en) | 2013-07-03 | 2013-07-03 | Compounds |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB1311951.6A GB2515785A (en) | 2013-07-03 | 2013-07-03 | Compounds |
Publications (2)
Publication Number | Publication Date |
---|---|
GB201311951D0 true GB201311951D0 (en) | 2013-08-14 |
GB2515785A GB2515785A (en) | 2015-01-07 |
Family
ID=48999472
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB1311951.6A Withdrawn GB2515785A (en) | 2013-07-03 | 2013-07-03 | Compounds |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB2515785A (en) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW201613919A (en) | 2014-07-02 | 2016-04-16 | Pharmacyclics Llc | Inhibitors of Bruton's tyrosine kinase |
MX2017009571A (en) * | 2015-01-23 | 2018-09-27 | Aclaris Therapeutics Inc | Heterocyclic itk inhibitors for treating inflammation and cancer. |
WO2017007755A1 (en) | 2015-07-06 | 2017-01-12 | Rodin Therapeutics, Inc. | Heterobicyclic n-aminophenyl-amides as inhibitors of histone deacetylase |
LT3319959T (en) | 2015-07-06 | 2021-12-27 | Alkermes, Inc. | Hetero-halo inhibitors of histone deacetylase |
WO2017035354A1 (en) | 2015-08-26 | 2017-03-02 | Blueprint Medicines Corporation | Compounds and compositions useful for treating disorders related to ntrk |
EP3170822A1 (en) | 2015-11-18 | 2017-05-24 | AGV Discovery | Azaindole derivatives and their use as erk kinase inhibitors |
RU2018122089A (en) | 2015-11-19 | 2019-12-25 | Блюпринт Медсинс Корпорейшн | COMPOUNDS AND COMPOSITIONS SUITABLE FOR THE TREATMENT OF NTRK DISORDERS |
CN106749268B (en) * | 2015-11-24 | 2020-10-09 | 广东东阳光药业有限公司 | Heteroaromatic compounds and their use in medicine |
SG11201906164RA (en) | 2017-01-11 | 2019-08-27 | Rodin Therapeutics Inc | Bicyclic inhibitors of histone deacetylase |
JP7152471B2 (en) | 2017-08-07 | 2022-10-12 | ロダン・セラピューティクス,インコーポレーテッド | Bicyclic inhibitor of histone deacetylase |
EP3833350A4 (en) | 2018-08-10 | 2022-05-18 | Aclaris Therapeutics, Inc. | Pyrrolopyrimidine itk inhibitors |
WO2022140246A1 (en) | 2020-12-21 | 2022-06-30 | Hangzhou Jijing Pharmaceutical Technology Limited | Methods and compounds for targeted autophagy |
CN115028633B (en) * | 2021-03-08 | 2023-12-22 | 药雅科技(上海)有限公司 | Preparation and application of pyrrolopyrimidine compound |
CN115043841B (en) * | 2021-03-09 | 2024-04-09 | 药雅科技(上海)有限公司 | Preparation and application of heterocyclic compound serving as BTK inhibitor |
CN115073469B (en) * | 2021-03-15 | 2023-12-22 | 药雅科技(上海)有限公司 | Preparation and application of pyrrolopyrimidine compound as kinase inhibitor |
EP4212531A1 (en) | 2022-01-14 | 2023-07-19 | AGV Discovery | Azaindole derivatives and their use as erk kinase inhibitors |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2008508303A (en) * | 2004-07-27 | 2008-03-21 | エスジーエックス ファーマシューティカルズ、インコーポレイテッド | Pyrrolo-pyridine kinase modulator |
WO2006058074A1 (en) * | 2004-11-22 | 2006-06-01 | Vertex Pharmaceuticals Incorporated | Pyrrolopyrazines and pyrazolopyrazines useful as inhibitors of protein kinases |
EP2815750A1 (en) * | 2006-12-21 | 2014-12-24 | Vertex Pharmaceuticals Incorporated | 5-cyano-4-(pyrrolo [2,3b] pyridine-3-yl)-pyrimidine derivatives useful as protein kinase inhibitors |
CA2728559A1 (en) * | 2008-07-03 | 2010-01-07 | Exelixis Inc. | Cdk modulators |
US8435980B2 (en) * | 2009-07-15 | 2013-05-07 | Abbvie Inc. | Pyrrolopyridine inhibitors of kinases |
-
2013
- 2013-07-03 GB GB1311951.6A patent/GB2515785A/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
GB2515785A (en) | 2015-01-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20171851T1 (en) | Tetrahydropyrrolothiazine compounds | |
HK1222658A1 (en) | Cyanotriazole compounds | |
GB201309085D0 (en) | Compounds | |
GB201302927D0 (en) | Compounds | |
GB201310542D0 (en) | Compounds | |
GB201311951D0 (en) | Compounds | |
GB201309508D0 (en) | Compounds | |
HK1212695A1 (en) | Azetidinyloxyphenylpyrrolidine compounds | |
GB201320636D0 (en) | Compounds | |
GB201319363D0 (en) | Compounds | |
GB201317619D0 (en) | Compounds | |
GB201312901D0 (en) | Compounds | |
GB201311953D0 (en) | Compounds | |
EP3010923A4 (en) | Pyrroloquinazoline compounds | |
EP2948457A4 (en) | Compounds | |
GB201318461D0 (en) | Compounds | |
GB201316014D0 (en) | Compounds | |
GB201310460D0 (en) | Compounds | |
GB201306794D0 (en) | Compounds | |
GB201322855D0 (en) | Compounds | |
GB201322028D0 (en) | Compounds | |
GB201321553D0 (en) | Compounds | |
GB201321554D0 (en) | Compounds | |
GB201321283D0 (en) | Compounds | |
GB201318323D0 (en) | Compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WAP | Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1) |